| A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032 (NCT04086121) | Boehringer Ingelheim | 2019-09-24 |
| A 4-week Study to Test Different Doses of BI 1265162 in Adolescents and Adults With Cystic Fibrosis Using the Respimat® Inhaler - BALANCE - CF™1 (NCT04059094) | Boehringer Ingelheim | 2019-09-16 |
| A Study Based on Data From German Registries That Looks at Characteristics of People Who Take the Medicine Empagliflozin for Type 2 Diabetes (NCT04098575) | Boehringer Ingelheim | 2019-09-16 |
| A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 (NCT04065295) | Boehringer Ingelheim | 2019-09-09 |
| A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 894416 in the Blood (NCT04060719) | Boehringer Ingelheim | 2019-09-04 |
| A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis (NCT04015518) | Boehringer Ingelheim | 2019-07-31 |
| A Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood Pressure (NCT03979820) | Boehringer Ingelheim | 2019-07-31 |
| This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain (NCT03993119) | Boehringer Ingelheim | 2019-07-30 |
| A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy (NCT04002310) | Boehringer Ingelheim | 2019-07-26 |
| A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1323495 in the Blood (NCT04011241) | Boehringer Ingelheim | 2019-07-24 |
| A Study in Healthy Men and Women to Test Which Effects Memantine and BI 425809 Have on Each Other (NCT03988803) | Boehringer Ingelheim | 2019-07-17 |
| Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma (NCT03971539) | Boehringer Ingelheim | 2019-07-15 |
| A Study to Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD) (NCT03861234) | Boehringer Ingelheim | 2019-06-27 |
| A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) and BI 754111 or BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) (NCT03964233) | Boehringer Ingelheim | 2019-06-20 |
| A Study to Test How Well Healthy Men Tolerate Different Doses of BI 706321 (NCT03971695) | Boehringer Ingelheim | 2019-06-18 |
| A Study to Find the Best Dose of BI 836880 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer (NCT03972150) | Boehringer Ingelheim | 2019-06-12 |
| A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT03979807) | Boehringer Ingelheim | 2019-06-10 |
| Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®) (NCT03954132) | Boehringer Ingelheim | 2019-06-07 |
| A Study in Healthy Men to Test the Effects of Different Doses of BI 1467335 on MAO-B Activity in the Brain. (NCT03927209) | Boehringer Ingelheim | 2019-06-06 |
| Observational Study to Evaluate Safety of Idarucizumab in Pediatric Patients (NCT02798107) | Boehringer Ingelheim | 2019-05-20 |
| This Study in Healthy Men and Women Tests Whether BI 409306 Has an Effect on the ECG (Thorough QT Study) (NCT03934203) | Boehringer Ingelheim | 2019-05-09 |
| Global Atrophie Biomarker Evaluation Study (GABiE) (NCT03935126) | Boehringer Ingelheim | 2019-05-07 |
| A Study in Healthy Men That Tests if Taking BI 1265162 by Mouth, Intravenously, or Inhaled Influences the Amount of BI 1265162 in the Blood (NCT03907280) | Boehringer Ingelheim | 2019-04-23 |
| A Study in Healthy Men to Test Whether BI 1358894 Reduces Druginduced Panic Symptoms (NCT03904576) | Boehringer Ingelheim | 2019-04-18 |
| A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) (NCT03820726) | Boehringer Ingelheim | 2019-04-16 |
| A Study to Observe the Effectiveness of Empagliflozin, Other SGLT-2 Inhibitors, or DPP-4 Inhibitors in Patients With Type 2 Diabetes (NCT03817463) | Boehringer Ingelheim | 2019-04-15 |
| This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia (NCT03859973) | Boehringer Ingelheim | 2019-04-15 |
| A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1291583 in the Blood (NCT03890887) | Boehringer Ingelheim | 2019-04-12 |
| A Study in Healthy Men and Women to Test Which Effects Donepezil and BI 425809 Have on Each Other (NCT03905096) | Boehringer Ingelheim | 2019-04-12 |
| A Study in Healthy Men and Women to Test if Taking Different Formulations of BI 730357 Tablets Influences the Amount of BI 730357 in the Blood (NCT03886272) | Boehringer Ingelheim | 2019-04-11 |
| A Study in Healthy Men to Test if Taking Different Formulations of BI 1358894 With or Without Food Influences the Amount of BI 1358894 in the Blood (NCT03892616) | Boehringer Ingelheim | 2019-04-08 |
| This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated (NCT03747926) | Boehringer Ingelheim | 2019-04-05 |
| A Study in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated (NCT03868540) | Boehringer Ingelheim | 2019-03-28 |
| A Study About How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated in Healthy Japanese Men (NCT03875001) | Boehringer Ingelheim | 2019-03-25 |
| A Study in Healthy Men to Test Whether Food Affects the Amount of BI 894416 in the Blood (NCT03871595) | Boehringer Ingelheim | 2019-03-20 |
| Platform Trial Evaluating Safety and Efficacy of Ezabenlimab Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours (NCT03697304) | Boehringer Ingelheim | 2019-03-19 |
| A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1358894 in the Blood (NCT03843151) | Boehringer Ingelheim | 2019-03-19 |
| A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is (NCT03835481) | Boehringer Ingelheim | 2019-03-18 |
| BI 705564 in Patients With Systemic Lupus Erythematosus (SLE) (NCT03771885) | Boehringer Ingelheim | 2019-03-16 |
| Impact of Tiotropium Add-on Therapy in Patients With Asthma (NCT03964220) | Boehringer Ingelheim | 2019-03-15 |
| A Study in People With Depression to Test the Effects of BI 1358894 on Parts of the Brain That Are Involved in Emotions (NCT03854578) | Boehringer Ingelheim | 2019-03-12 |
| A Study to Test How Different Doses of BI 685509 Are Tolerated in Patients With Liver Problems (NCT03842761) | Boehringer Ingelheim | 2019-03-06 |
| Characteristics of Pts Initiating Spiriva Respimat in Asthma (NCT03692676) | Boehringer Ingelheim | 2019-03-05 |
| Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib (NCT03710824) | Boehringer Ingelheim | 2019-02-28 |
| A Study to Test How Food Influences the Amount of BI 1291583 in the Blood of Healthy Men (NCT03837964) | Boehringer Ingelheim | 2019-02-27 |
| A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated (NCT03822832) | Boehringer Ingelheim | 2019-02-12 |
| A Study in Healthy People to Test if Taking Different Formulations of BI 425809 Tablets Influences the Amount of BI 425809 in the Blood (NCT03817476) | Boehringer Ingelheim | 2019-02-11 |
| A Study Testing How BI 655130 Works in Patients With Fistulizing Crohn's Disease (NCT03752970) | Boehringer Ingelheim | 2019-02-05 |
| A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking (NCT03958071) | Boehringer Ingelheim | 2019-02-01 |
| Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis (NCT03782792) | Boehringer Ingelheim | 2019-01-31 |
| EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) (NCT03594110) | Boehringer Ingelheim | 2019-01-31 |
| A Study in Healthy Men to Measure the Amount of BI 730357 in the Blood When Taken as a Tablet (NCT03804671) | Boehringer Ingelheim | 2019-01-31 |
| A Study in Healthy Men to Find Out How Well Different Doses of BI 764122 Are Tolerated and Whether Food Affects the Amount of BI 764122 in the Blood (NCT03794323) | Boehringer Ingelheim | 2019-01-30 |
| A Study to Test How Food Influences the Amount of BI 1323495 in the Blood of Healthy Men (NCT03802331) | Boehringer Ingelheim | 2019-01-28 |
| This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091 (NCT03780725) | Boehringer Ingelheim | 2019-01-22 |
| This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 730357 Are Taken up in the Body and How Well They Are Tolerated (NCT03793621) | Boehringer Ingelheim | 2019-01-21 |
| A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes (NCT03761797) | Boehringer Ingelheim | 2019-01-15 |
| A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet (NCT03783000) | Boehringer Ingelheim | 2019-01-15 |
| A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 730357 in the Blood (NCT03782987) | Boehringer Ingelheim | 2019-01-10 |
| PraxbindTM India PMS Program (NCT03359889) | Boehringer Ingelheim | 2018-12-26 |
| This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How BI 1358894 Affects the Way the Body Breaks Down Midazolam (NCT03754959) | Boehringer Ingelheim | 2018-12-18 |
| The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread (NCT03659136) | Boehringer Ingelheim | 2018-11-28 |
| Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT03717012) | Boehringer Ingelheim | 2018-11-15 |
| This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke (NCT03258645) | Boehringer Ingelheim | 2018-11-15 |
| A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 894416 in the Blood (NCT03722173) | Boehringer Ingelheim | 2018-11-13 |
| A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) (NCT03675581) | Boehringer Ingelheim | 2018-11-08 |
| BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis (NCT03648541) | Boehringer Ingelheim | 2018-10-29 |
| This Study in Healthy Volunteers Determines the Amount of BI 730460 in the Blood When Taken as Tablet. It Looks at How Different Doses of BI 730460 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How Food Influences the Amount of BI 730460 in the Blood. (NCT03483077) | Boehringer Ingelheim | 2018-10-09 |
| A Study to Compare the Amount of Meloxicam in the Blood When it is Taken as Capsules or as Tablets (NCT03684265) | Boehringer Ingelheim | 2018-10-05 |
| A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes (NCT03993132) | Boehringer Ingelheim | 2018-10-01 |
| Post-authorization Safety Study in Type 2 Diabetic Patients in Saudi Arabia Treated With Empagliflozin to Assess the Incidence of Ketoacidosis, Severe Complications of Urinary Tract Infection, Volume Depletion, and Dehydration (NCT03764631) | Boehringer Ingelheim | 2018-09-26 |
| This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is (NCT03635099) | Boehringer Ingelheim | 2018-09-17 |
| A Study in Healthy Men to Find Out How BI 425809 is Taken up and Handled by the Body (NCT03654170) | Boehringer Ingelheim | 2018-09-11 |
| A Study in Healthy Men to Test How BI 730357 is Processed by the Body (NCT03664011) | Boehringer Ingelheim | 2018-09-10 |
| This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills (NCT03629054) | Boehringer Ingelheim | 2018-08-27 |
| Regulatory Request NIS in Korea (NCT03642717) | Boehringer Ingelheim | 2018-08-21 |
| A Study in Healthy People to Measure the Amount of BI 655130 in the Blood After Injecting Different Doses Into Different Parts of the Body (NCT03617835) | Boehringer Ingelheim | 2018-08-16 |
| A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler (NCT03663569) | Boehringer Ingelheim | 2018-08-15 |
| The OPTI Study in Spain Looks at the History Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Inhaled Steroids. (NCT03611777) | Boehringer Ingelheim | 2018-08-14 |
| A Study in Healthy Japanese Men to Test How Different Doses of BI 690517 Are Taken Up in the Body and How Well They Are Tolerated (NCT03608072) | Boehringer Ingelheim | 2018-08-06 |
| This Study in Healthy Men Tests How Different Doses of BI 1323495 Are Taken up in the Body and How Well They Are Tolerated. (NCT03588390) | Boehringer Ingelheim | 2018-07-31 |
| A Study to Test Different Doses of BI 456906 in Patients With Obesity (NCT03591718) | Boehringer Ingelheim | 2018-07-26 |
| This Study in Healthy Men Tests How Different Doses of BI 1265162 Are Taken up in the Body and How Well They Are Tolerated. (NCT03576144) | Boehringer Ingelheim | 2018-07-11 |
| A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours (NCT03468426) | Boehringer Ingelheim | 2018-07-05 |
| The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa (NCT03521635) | Boehringer Ingelheim | 2018-07-03 |
| This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors) (NCT03449381) | Boehringer Ingelheim | 2018-06-20 |
| This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 1015550 Are Taken up in the Body and How Well They Are Tolerated. (NCT03542344) | Boehringer Ingelheim | 2018-06-04 |
| This Study in Healthy Men Tests How Itraconazole Influences the Amount of BI 1015550 in the Blood (NCT03403439) | Boehringer Ingelheim | 2018-05-03 |
| This Study in Healthy Men and Women Tests How the Body Takes up BI 409306 (NCT03505151) | Boehringer Ingelheim | 2018-04-27 |
| This Study in Healthy Men Tests How the Body Takes up BI 1467335 (NCT03483506) | Boehringer Ingelheim | 2018-04-10 |
| A Study Using Swedish Registries to Find Out How Many People With Type 2 Diabetes Had Cardiovascular Disease and Started Treatment With Empagliflozin Between 2015 and 2017 (NCT04927858) | Boehringer Ingelheim | 2018-04-02 |
| Digital Auscultation Test - IPF Data Collection (NCT03503188) | Boehringer Ingelheim | 2018-03-28 |
| BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis (NCT03482635) | Boehringer Ingelheim | 2018-03-27 |
| This Study Looks at the Effects of Idarucizumab in Patients Who Take Dabigatran and Need Emergency Surgery or Are Bleeding (NCT03343704) | Boehringer Ingelheim | 2018-03-26 |
| Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM (NCT03429543) | Boehringer Ingelheim | 2018-03-20 |
| This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms (NCT03448419) | Boehringer Ingelheim | 2018-03-20 |
| Greek NIS Spiolto ELLACTO (NCT03419962) | Boehringer Ingelheim | 2018-03-19 |
| This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated. (NCT03422068) | Boehringer Ingelheim | 2018-03-16 |
| A Study That Looks at the Function of the Heart in Patients With Heart Failure Who Take Empagliflozin (NCT03332212) | Boehringer Ingelheim | 2018-03-01 |
| This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer (NCT03433898) | Boehringer Ingelheim | 2018-02-23 |